[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wang et al., 2016 - Google Patents

High-throughput analysis of native antibody repertoires for therapeutics discovery

Wang et al., 2016

View PDF
Document ID
13637781648871076421
Author
Wang B
et al.
Publication year

External Links

Snippet

Adaptive immunity is the foundation of recognition and protection against a diverse array of pathogens. The humoral arm of adaptive immunity whose most significant effector mechanism relies on antibodies is critical for protection against many viral and bacterial …
Continue reading at repositories.lib.utexas.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Similar Documents

Publication Publication Date Title
Gilman et al. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors
US20210302422A1 (en) Systems and methods for simultaneous detection of antigens and antigen specific antibodies
EP3421592B1 (en) Identification of polynucleotides associated with a sample
US20180179300A1 (en) Generation of binding molecules
JP6211931B2 (en) Methods and reagents for producing monoclonal antibodies
Wang et al. Facile discovery of a diverse panel of anti-Ebola virus antibodies by immune repertoire mining
De Kruif et al. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous VH genes
Yacoob et al. Differences in allelic frequency and CDRH3 region limit the engagement of HIV Env immunogens by putative VRC01 neutralizing antibody precursors
Zhang Evolution of phage display libraries for therapeutic antibody discovery
Wang et al. Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH: VL libraries from immunized animals
Walker et al. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library
Lei et al. Antigen-specific single B cell sorting and monoclonal antibody cloning in guinea pigs
He et al. Hidden lineage complexity of glycan-dependent HIV-1 broadly neutralizing antibodies uncovered by digital panning and native-like gp140 trimer
WO2022060893A1 (en) Antibodies that target hla-e-host peptide complexes and uses thereof
Chen et al. Characterization of human IgG repertoires in an acute HIV-1 infection
Xie et al. mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies
Gilchuk et al. Proteo-genomic analysis identifies two major sites of vulnerability on ebolavirus glycoprotein for neutralizing antibodies in convalescent human plasma
Minatel et al. Nanobodies: a promising approach to treatment of viral diseases
Houimel et al. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library
Wang High-throughput analysis of native antibody repertoires for therapeutics discovery
Houimel The analysis of VH and VL genes repertoires of Fab library built from peripheral B cells of human rabies virus vaccinated donors
Hutchings et al. Phage display technology and its impact in the discovery of novel protein-based drugs
Ehling Synthetic selection and engineering of antibodies
Setliff High-Resolution Interrogation of Antibody Repertoires Using Next-Generation Sequencing
US20240240173A1 (en) Identification of Polynucleotides Associated with a Sample